A major trial of genetic screening of new-born children has begun in England, aimed at identifying more than 200 rare conditions.
NHS England plans to use whole genome sequencing to screen up to 100,000 children using umbilical cord blood samples....
5 months ago
The JAK inhibitor ruxolitinib could improve the treatment of chronic myeloid leukaemia (CML), a European conference has been told.
A phase 2 trial including the drug alongside standard treatment found an increase in the proportion of patients with...
5 months ago
